MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | -71.8% | 87,113 | -27.0% | 0.00% | – |
| Q2 2023 | $394 | -21.2% | 119,345 | -1.7% | 0.00% | – |
| Q1 2023 | $500 | -29.3% | 121,377 | +0.7% | 0.00% | – |
| Q4 2022 | $707 | -99.9% | 120,519 | +7.6% | 0.00% | – |
| Q3 2022 | $758,000 | +17.3% | 112,039 | -19.9% | 0.00% | – |
| Q2 2022 | $646,000 | +17.2% | 139,819 | +1.3% | 0.00% | – |
| Q1 2022 | $551,000 | -22.6% | 138,034 | +20.6% | 0.00% | – |
| Q4 2021 | $712,000 | -92.3% | 114,447 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $9,250,000 | -70.6% | 980,896 | -57.7% | 0.00% | -66.7% |
| Q2 2021 | $31,475,000 | -34.6% | 2,317,747 | -22.1% | 0.00% | -40.0% |
| Q1 2021 | $48,121,000 | -45.3% | 2,974,087 | -10.0% | 0.01% | -44.4% |
| Q4 2020 | $87,929,000 | +158.2% | 3,304,346 | +80.7% | 0.01% | +125.0% |
| Q3 2020 | $34,049,000 | +95.3% | 1,828,619 | +145.4% | 0.00% | +100.0% |
| Q2 2020 | $17,438,000 | – | 745,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |